Our results revealed the potential clinical utility of exosomes as novel carriers of miRNAs for inhibiting metastasis of CRC upon activation of the CXCL12/CXCR7 axis by exerting effects on CAFs, providing potential therapeutic strategies and drug targets. Here, CXCL12 is linked to colorectal carcinoma.